Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


American Medical Systems Parent Company Reaches More Vaginal Mesh Settlements

The parent company of American Medical Systems, Inc. announced earlier this week that had reached an agreement to settle another 10,000 vaginal mesh lawsuits. The new accord is expected to cost the company around $400 million. “We believe these settlements … Continue reading

Axiron Plaintiff Blames Testosterone Drug for Heart Attack

A testosterone lawsuit has been filed by a New Jersey man who suffered a heart attack just a month after beginning treatment with Axiron, a hormone-raising therapy. The New Jersey Law Journal reports that the plaintiff, who resides in Hopatcong, … Continue reading

Bard Opposes Motion to Produce Employee Docs in Federal Transvaginal Mesh Litigation

A transvaginal mesh manufacturer has opposed a request from plaintiffs to hand over the personnel files of more than 40 employees, according to court records. TheNationalLawJournal.com recently reported that the originally motion was filed in a federal multidistrict litigation involving … Continue reading

Medicare Agency Plans 25% Cut in Nursing Home Patients on Risperdal and other Drugs

A new plan to curtail the number of nursing home patients taking Risperdal and other antipsychotic drugs is ambitious, patient advocates say, but will remain ineffective without proper regulation. The plan was introduced in September by the Centers for Medicare … Continue reading

Boston Man Reaffirms Power Morcellator Stance in ‘Cancer Letter’ Editorial

The Boston man whose campaign to end power morcellator surgery has spiraled across the U.S. over the past year took the mic this week to raise awareness on the issue. This time, it’s an editorial via The Cancer Letter that … Continue reading

DePuy Hip Replacement Trial Continues, As Jury Hears from Clinical Research VP

DePuy Orthopaedics’ global vice president of clinical research took the stand Monday, as the nation’s first Pinnacle hip replacement trial continued this week in Texas federal court. According to Reuters, the witness was grilled by the Plaintiff’s attorney about the … Continue reading

AndroGel Maker Colluded To Keep Generics Off Market, FTC Lawsuit Claims

The Federal Trade Commission (FTC) is taking the manufacturer of AndroGel to court, claiming it colluded with another pharmaceutical company to keep a cheaper, generic version of the testosterone treatment off the market. In a lawsuit filed last week, the … Continue reading

Boston Doctor Waves off Power Morcellator Threats

A Boston doctor who began campaigning to end power morcellator surgery after his wife’s uterine cancer diagnosis says he is “not fazed” by a manufacturer’s recent threat to sue him for damages, according to Medscape Medical News. An interview with Dr. Hooman … Continue reading

$3.27 Million Transvaginal Mesh Victory Gets Attention Abroad

A woman’s recent transvaginal mesh victory in a case against Johnson & Johnson’s Ethicon is making waves outside the U.S., especially in Scotland, where a campaign to ban the implants continues to gain more supporters, according to the Daily Record. … Continue reading

Ethicon Plaintiff Wins $3.27 Million in Transvaginal Mesh Suit

West Virginia jurors awarded $3.27 million last Friday to the plaintiff in a transvaginal mesh case against Johnson & Johnson’s Ethicon unit, according to Reuters.com. The verdict was reached on September 5th in the U.S. District Court, Southern District of West Virginia, … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content